This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A short examination of how index fund return variance evolves across decades and what it means for risk budgets.
25,652 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A veteran wealth manager makes a bold move into defense stocks as geopolitical tensions rise. Learn the strategy, ris...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
In a move that stirs controversy, a $1.7 billion fund is being created to compensate allies in a settlement tied to T...
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Retail investors chasing nat gas bets via front-month futures confront a hidden drag. The roll yield trap that gnaws ...
Healthcare investing offers breadth and specialty. This guide explains FHLC and BBH, how they differ, and how to deci...
The Humanoid Robotics ETF BOTT surged 114% in the last year, yet its concentrated Korean and Chinese holdings expose ...
A notable stake reduction by pacific ridge capital trims its NWPX position, signaling a shift in exposure. This guide...
Starting with $1,000? Discover the smartest Vanguard with $1,000 to build a durable, low-cost core. Learn allocations...
A viral Oscars quip turns into a teachable moment about money. This personal finance guide breaks down budgeting, sav...
Kazakhstan's central bank is considering a $350 million crypto-related portfolio funded in part by gold reserves. Off...